Back
46
33
Also listed as
BUGDF
OTC
Day Range
$5.65
$5.65
52-Week Range
$4.75
$5.65
Volume
300
50D / 200D Avg
$5.36
/
$4.98
Prev Close
$5.65
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (631 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 0.6 | 0.2 |
| P/B | 0.2 | 3.0 |
| ROE % | 25.9 | 3.6 |
| Net Margin % | 29.9 | 3.8 |
| Rev Growth 5Y % | 19.2 | 9.9 |
| D/E | 0.0 | 0.2 |
Analyst Price Target
No analyst coverage available
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2027 |
$0.00
$0.00 – $0.00
|
28.09B | 0 |
| FY2026 |
$0.00
$0.00 – $0.00
|
26.24B | 0 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2025-12-31 | N/A | $0.07 | — |
| 2025-11-06 | N/A | $0.07 | — |
| 2025-07-31 | N/A | $0.07 | — |
| 2025-04-23 | N/A | $0.06 | — |
| 2025-02-27 | N/A | $0.06 | — |
| 2024-11-07 | N/A | $0.07 | — |
| 2024-08-08 | N/A | $0.06 | — |
| 2024-05-02 | N/A | $0.06 | — |
Dividend History
7 yr streakYield
0.03%
Payout Ratio
0.53%
Growth (3Y)
17.11%
Growth (5Y)
8.58%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Mar 18, 2026 | May 12, 2026 | $0.28 | 6.01% |
| Aug 15, 2025 | Sep 29, 2025 | $0.06 | 3.10% |
| Mar 20, 2025 | May 13, 2025 | $0.09 | 3.03% |
| Aug 26, 2024 | Sep 06, 2024 | $0.06 | 2.11% |
| Mar 13, 2024 | May 10, 2024 | $0.09 | 2.10% |
| Aug 24, 2023 | Sep 06, 2023 | $0.04 | 1.62% |
| Mar 13, 2023 | May 10, 2023 | $0.07 | 1.54% |
| Aug 25, 2022 | Sep 08, 2022 | $0.03 | 1.77% |
| Mar 11, 2022 | May 10, 2022 | $0.06 | 2.06% |
| Aug 26, 2021 | Sep 08, 2021 | $0.04 | 2.62% |
| Mar 10, 2021 | May 10, 2021 | $0.07 | 2.31% |
| Aug 19, 2020 | Sep 03, 2020 | $0.04 | 2.58% |
| Mar 26, 2020 | Apr 30, 2020 | $0.06 | 2.67% |
| Aug 22, 2019 | Sep 05, 2019 | $0.04 | 1.66% |
| Mar 06, 2019 | May 08, 2019 | $0.06 | 1.62% |
| Aug 22, 2018 | Sep 05, 2018 | $0.03 | 1.60% |
| Mar 07, 2018 | May 08, 2018 | $0.05 | 1.28% |
| Aug 22, 2017 | Sep 06, 2017 | $0.03 | 1.32% |
| Mar 13, 2017 | May 15, 2017 | $0.04 | 1.47% |
| Aug 15, 2016 | Aug 26, 2016 | $0.03 | 1.36% |
Key Takeaways
Revenue grew 19.15% annually over 5 years — strong growth
ROE of 25.88% indicates high profitability
Net margin of 29.89% shows strong profitability
Debt/Equity of 0.02 — conservative balance sheet
Generating 6.59B in free cash flow
P/E of 0.60 — trading at a low valuation
Growth
Revenue Growth (5Y)
19.15%
Revenue (1Y)-2.35%
Earnings (1Y)-3.46%
FCF Growth (3Y)10.30%
Quality
Return on Equity
25.88%
ROIC21.22%
Net Margin29.89%
Op. Margin34.94%
Safety
Debt / Equity
0.02
Current Ratio4.60
Interest Coverage1324.95
Valuation
P/E Ratio
0.60
Forward P/EN/A
P/B Ratio0.15
EV/EBITDA-0.30
Dividend Yield0.03%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -2.35% | Revenue Growth (3Y) | -0.52% |
| Earnings Growth (1Y) | -3.46% | Earnings Growth (3Y) | 3.50% |
| Revenue Growth (5Y) | 19.15% | Earnings Growth (5Y) | 57.63% |
| Profitability | |||
| Revenue (TTM) | 25.11B | Net Income (TTM) | 7.51B |
| ROE | 25.88% | ROA | 20.60% |
| Gross Margin | 50.52% | Operating Margin | 34.94% |
| Net Margin | 29.89% | Free Cash Flow (TTM) | 6.59B |
| ROIC | 21.22% | FCF Growth (3Y) | 10.30% |
| Safety | |||
| Debt / Equity | 0.02 | Current Ratio | 4.60 |
| Interest Coverage | 1324.95 | ||
| Dividends | |||
| Dividend Yield | 0.03% | Payout Ratio | 0.53% |
| Dividend Growth (3Y) | 17.11% | Dividend Growth (5Y) | 8.58% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | 0.60 | Forward P/E | N/A |
| P/B Ratio | 0.15 | P/S Ratio | 0.18 |
| PEG Ratio | -5.76 | Forward PEG | N/A |
| EV/EBITDA | -0.30 | Fwd EV/EBITDA | -0.18 |
| Forward P/S | 0.17 | Fwd Earnings Yield | N/A |
| FCF Yield | 146.77% | ||
| Market Cap | 4.49B | Enterprise Value | -2.61B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 25.11B | 25.72B | 25.38B | 20.72B | 12.46B |
| Net Income | 7.51B | 7.77B | 7.01B | 4.94B | 1.22B |
| EPS (Diluted) | 8.51 | 8.96 | 8.08 | 5.69 | 1.40 |
| Gross Profit | 12.69B | 13.21B | 12.48B | 9.62B | 4.73B |
| Operating Income | 8.77B | 9.17B | 8.50B | 6.01B | 1.52B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 36.43B | 32.65B | 29.21B | 24.26B | 20.86B |
| Total Liabilities | 5.60B | 4.85B | 5.11B | 4.25B | 3.24B |
| Shareholders' Equity | 30.52B | 27.49B | 23.80B | 19.71B | 17.29B |
| Total Debt | 487.29M | 139.44M | 91.14M | 63.28M | 94.37M |
| Cash & Equivalents | 7.59B | 3.26B | 3.77B | 2.09B | 1.80B |
| Current Assets | 18.77B | 16.73B | 15.68B | 11.42B | 8.06B |
| Current Liabilities | 4.08B | 3.83B | 4.18B | 3.41B | 2.28B |
Strategy Scores
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
#358 of 826
#118 of 203
Recent Activity
Exited
Contrarian Investing (David Dreman)
Mar 26, 2026
Exited
Defensive Investing (Benjamin Graham)
Mar 26, 2026
Entered
Deep Value Investing (Seth Klarman)
Mar 24, 2026
Entered
Contrarian Investing (David Dreman)
Mar 24, 2026
Entered
Defensive Investing (Benjamin Graham)
Mar 24, 2026
Entered
Value Investing (Warren Buffett)
Mar 24, 2026